Dr. Ralph T. Rucinski, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 950 S Court St, Crown Point, IN 46307 Phone: 219-662-3855 |
Dr. Kristin J Collard, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1 Professional Ctr Ste 206, 2100 North Main Street, Crown Point, IN 46307 Phone: 219-663-9500 Fax: 219-663-9595 |
Jerry Edward Lambert Jr., DDS Dentist Medicare: Medicare Enrolled Practice Location: 301 S Court St, Crown Point, IN 46307 Phone: 219-663-1207 Fax: 219-663-6474 |
Dr. Natalie Joan Popovich, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 223 S Court St, Crown Point, IN 46307 Phone: 219-663-0252 |
Dr. Simon George Abu-aita, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 698 E Burrell Dr, Crown Point, IN 46307 Phone: 219-662-7668 |
Dr. Bret A Bologna, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 11039 Broadway, Suite A, Crown Point, IN 46307 Phone: 219-663-7193 Fax: 219-663-7833 |
Dr. Sylvie Nicole Kristoff, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 10780 Randolph St, Crown Point, IN 46307 Phone: 219-663-6878 |
News Archive
Verenium Corporation, a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines Verenium's Purifine PLC enzyme and Desmet Ballestra's engineering services and equipment.
The UK government's current alcohol guidelines are unrealistic and largely ignored because they have little relevance to people's drinking habits, according to a new report by the Sheffield Alcohol Research Group (SARG) in collaboration with the University of Stirling.
"The number of Americans living in poverty is at an all-time high, with close to 50 million people living below the poverty line," therefore "we desperately need a national dialogue about the unique afflictions of the bottom 50 million, paying particular attention to their neglected tropical diseases, which represent important stealth reasons trapping them in a vicious cycle of poverty," Peter Hotez, founding dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, writes in an Austin-American Statesman opinion piece.
Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
› Verified 6 days ago